Cervical Cancer Antidote Research


Cervical cancer is now there is no antidote, but the tobacco plant could be an alternative. It’s one of the benefits of tobacco plants. Based on research, the plant is capable of being a carrier of genetic development of Human Papilloma Virus (HPV) produces germ cells which later can be antibodies to the virus triggers cervical cancer.

Recent research on cervical cancer antidote is now being done by scientists from Georgetown University Medical Center (Georgetown University Medical Center) and University of North Carolina, United States.


After investigation, it turns genetically tobacco plants containing a protein source that can stimulate antibodies against HPV that cause cervical cancer. The research project was funded three million dollars from the central government coffers as part of the farm legislation that was recently released Congress.

Chief Researcher at Georgetown University, Washington DC, Dr. Kenneth Dretchen said the idea of ​​research, among others, to develop antibodies against HPV that cause cervical cancer. For some reason with HPV do not breed well under normal conditions of microbiology. After investigation, it turns out the right environment for the development of germ cells were present in tobacco plants. Although it sounds strange and making it up, Dretchen said it has long been conducting research on HPV virus was at Georgetown.

However, the constraint is the lack of quantity of antibody needed to meet the need of healing on a large scale. The study was intended also to find solutions development quantity of virus antibodies.

Meanwhile, North Carolina State University will employ an expert in planting tobacco. They will produce and conduct tests of these antibodies, which will take 2-3 years before the laboratory tests performed. The study is one effort to seek treatment for cervical cancer, which until now not known antidote.